Baroda BNP Paribas Health And Wellness Fund · Regular · Growth
Baroda BNP Paribas Mutual Fund
NAV
₹10.5939
as of 14 Jul 2026
Expense Ratio
2.33%
AUM
₹555 Cr
Lumpsum returns (CAGR)
- 1Y
- +5.53%
- 3Y
- —
- 5Y
- —
- Since Inception
- +5.67%
SIP returns (XIRR)
- 1Y
- +19.43%
- 3Y
- —
- 5Y
- —
- Since Inception
- +17.37%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Risk Metrics
Trailing 1 year, annualised0.01
Sharpe Ratio
+0.02
Alpha
0.14
Beta
0.01
Sortino
11.56%
Std Dev
-11.93%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 May 2026- Pharmaceuticals & Biotechnology68.48%
- Healthcare Services17.52%
- Insurance7.27%
- Retailing1.65%
- IT - Services1.54%
- Healthcare Equipment & Supplies0.95%
Each sector links to the mutual funds most exposed to it.
Thinking about Baroda BNP Paribas Health And Wellness Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Limited9.09%
- 2Lupin Limited5.83%
- 3Laurus Labs Limited5.76%
- 4Abbott India Limited5.43%
- 5Torrent Pharmaceuticals Limited5.27%
- 6Ipca Laboratories Limited5.18%
- 7Apollo Hospitals Enterprise Limited4.66%
- 8Jb Chemicals & Pharmaceuticals Limited4.38%
- 9Fortis Healthcare Limited4.27%
- 10Astrazeneca Pharma India Limited4.12%
Investment Objective
Baroda BNP Paribas Health And Wellness Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Baroda BNP Paribas Health And Wellness Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Baroda BNP Paribas Mutual Fund. The fund has been operational for over 1 years. It manages assets worth ₹555 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.33%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations